Finance

Beta
Lists
INAB:NASDAQ
IN8bio Inc
$1.40
-3.45%
(-0.050) 1D
Jun 10, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INAB...
Open
$1.41
High
$1.50
Low
$1.38
Mkt. cap
13.79M
Avg. vol.
67.02K
Volume
37.67K
52-wk high
$2.90
52-wk low
$1.17
EPS
-$3.04
Beta
0.19
Shares outstanding
9.85M
No. of employees
18
Open
$1.41
High
$1.50
Low
$1.38
Mkt. cap
13.79M
Avg. vol.
67.02K
Volume
37.67K
52-wk high
$2.90
52-wk low
$1.17
EPS
-$3.04
Beta
0.19
Shares outstanding
9.85M
No. of employees
18
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to INAB in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for INAB in the last 3 months.
Highest
Current $1.40
$6.00 (+328.57%)
Average
$5.00 (+257.14%)
Lowest
$4.00 (+185.71%)
News stories
From sources across the web
About IN8bio Inc
CEO-
Employees18
Founded2016
Headquarters-
SectorBiotechnology
Websitein8bio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.49M
2.10M
2.65M
2.61M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.71M
1.86M
2.38M
2.65M
Operating expense
5.20M
3.97M
5.03M
5.27M
Total operating expenses
5.20M
3.97M
5.03M
5.27M
Operating income
-5.20M
-3.97M
-5.03M
-5.27M
Other non operating income
-
-
-
-
EBT including unusual items
-5.09M
-3.85M
-4.94M
-5.09M
EBT excluding unusual items
-5.09M
-3.85M
-4.94M
-5.09M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.09M
-3.85M
-4.94M
-5.09M
Net profit margin
-
-
-
-
Earnings per share
-1.24
-0.85
-0.45
-0.26
Interest and investment income
107.00K
113.00K
91.00K
176.00K
Interest expense
-
-
-
-
Net interest expenses
107.00K
113.00K
91.00K
176.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.66M
-3.60M
-4.67M
-4.91M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer